Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

SunEdison Shareholders Vote To Increase Number Of Authorized Shares

RELATED NEWS
Trade SUNE now with 

SunEdison, Inc. (SUNE: Quote) said Friday that, at its May 29 Annual Meeting, its shareholders voted to approve an amendment to the company's Amended and Restated Certificate of Incorporation to increase the number of the company's authorized shares of common stock issuable from 300 million to 700 million.

The increase in authorized shares of common stock will allow the company to satisfy issuances under future equity-based awards as well as issuances required upon conversion of the company's 2.00% Convertible Senior Notes Due 2018 and the company's 2.75% Convertible Senior Notes Due 2021.

Click here to receive FREE breaking news email alerts for SunEdison and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Specialty drugmaker Horizon Pharma plc (HZNP) on Friday managed to redomicile itself as an entity incorporated in Ireland following the completion of its $660 million acquisition of Vidara Therapeutics International plc. The deal will help it avoid paying the high rate of U.S. corporate taxes. The... Stocks showed a lack of direction over the course of the trading day on Friday after failing to sustain an initial upward move. Despite the choppy trading, the Dow once again managed to end the session at a new record closing high. The major averages turned in a mixed performance on the day. President Barack Obama delivered a statement Thursday evening thanking members of Congress for voting to approve legislation granting the U.S. military the authority to train and arm moderate Syrian rebels fighting against the terrorist group known as the Islamic State.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.